REFERENCES
- MacKay H T, MacKay A P. Abortion training in obstetrics and gynecology residency programs in the United States, 1991–1992. Fam Plann Perspect 1995; 27: 112–15
- Spitz A M, Velebil P, Strauss L T, et al. Pregnancy, abortion and birth rates among US adolescents - 1980, 1985, and 1990. J Am Med Assoc 1996; 275: 989–94
- Ministerio de Sanidad y Consumo del Estado Español. Informe sobre interrupción voluntaria del embarazo. Dirección General de Salud Publica, Madrid 1997; 21: 32
- Creinin M D, Wiebe E, Gold M. Methotrexate and misoprostol for early abortion in adolescent women. J Pediatr Adolesc Gynecol 1999; 12: 71–7
- Carbonell J LL, Varela L, Velazco A, Cabezas E, Tanda R, Sánchez C. Early abortion with 800 μg of misoprostol by the vaginal route. Contraception 1999; 59: 219–25
- Carbonell J LL, Varela L, Velazco A, Fernández C. The use of misoprostol for termination of early pregnancy. Contraception 1997; 55: 165–8
- Carbonell J LL, Varela L, Velazco A, Fernández C, Sánchez C. The use of misoprostol for abortion of ≤ 9 weeks’ gestation. Eur J Contracept Reprod Health Care 1997; 2: 181–5
- Hellman L M, Kobayashi M, Fillisti L, Lavenhar M, Cromb E. Growth and development of the human fetus prior to the twentieth week of gestation. Am J Obstet Gynecol 1969; 103: 789–98
- Winikoff B, Ellertson C, Clark S. Analysis of failure in medical abortion. Contraception 1996; 54: 323–7
- Donner A. Approaches to sample size estimations in the design of clinical trials. Stat Med 1984; 3: 199–214